Intraperitoneal administration of tetanus toxoid elicits a specific response of antibody-secreting cells in the peritoneal cavity.
Lue
C
C
Department of Microbiology, University of Alabama at Birmingham, 35294, USA.
Van den Wall Blake
A W
AW
Prince
S J
SJ
Julian
B A
BA
Tseng
M L
ML
Elson
C O
CO
Hale
H H
HH
Mestecky
J
J
D000907:Antibodies, Bacterial / Q000276:immunology*; D000921:Antibody-Producing Cells / Q000276:immunology*; D001773:Blood Cells / Q000276:immunology; D004847:Epithelial Cells; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D007963:Leukocytes, Mononuclear / Q000276:immunology*; D017737:Macrophages, Peritoneal / Q000276:immunology*; D008297:Male; D010529:Peritoneal Cavity / Q000166:cytology*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D013745:Tetanus Toxoid / Q000008:administration & dosage* / Q000276:immunology
D000907:Antibodies, Bacterial; D013745:Tetanus Toxoid